Related references
Note: Only part of the references are listed.FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-KB axis
Zhengxin Chen et al.
MOLECULAR THERAPY (2022)
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Lingxiang Wu et al.
CANCER DISCOVERY (2022)
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
Etsuko Yamamoto Hattori et al.
COMMUNICATIONS BIOLOGY (2022)
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Ronan Chaligne et al.
NATURE GENETICS (2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso et al.
CELL (2021)
Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation
Xiaoqing Fan et al.
ONCOGENESIS (2021)
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
Toshiro Hara et al.
CANCER CELL (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
NF1 regulates mesenchymal gliblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
Carolina Marques et al.
ELIFE (2021)
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
Laura M. Richards et al.
NATURE CANCER (2021)
Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL- rearranged B cell acute lymphoblastic leukemia
Juan Ramon Tejedor et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Cell Lineage-Based Stratification for Glioblastoma
Zilai Wang et al.
CANCER CELL (2020)
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Charles P. Couturier et al.
NATURE COMMUNICATIONS (2020)
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
Patrik Johansson et al.
CELL REPORTS (2020)
Runx2+Niche Cells Maintain Incisor Mesenchymal Tissue Homeostasis through IGF Signaling
Shuo Chen et al.
CELL REPORTS (2020)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2020)
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma
Stephen C. Mack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Fast, sensitive and accurate integration of single-cell data with Harmony
Ilya Korsunsky et al.
NATURE METHODS (2019)
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
Kai Zhao et al.
CELL DEATH & DISEASE (2019)
ELMER v.2: an R/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles
Tiago C. Silva et al.
BIOINFORMATICS (2019)
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Tathiane M. Malta et al.
NEURO-ONCOLOGY (2018)
HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis
Ivan V. Kulakovskiy et al.
NUCLEIC ACIDS RESEARCH (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
CEMiTool: a Bioconductor package for performing comprehensive modular co-expression analyses
Pedro S. T. Russo et al.
BMC BIOINFORMATICS (2018)
Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets
Ricard Argelaguet et al.
MOLECULAR SYSTEMS BIOLOGY (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer et al.
NATURE MEDICINE (2018)
RUNX2 Promotes Malignant Progression in Glioma
Daisuke Yamada et al.
NEUROCHEMICAL RESEARCH (2018)
Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance
Evan K. Noch et al.
WORLD NEUROSURGERY (2018)
Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi
Jean-Philippe Fortin et al.
BIOINFORMATICS (2017)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
GTRD: a database of transcription factor binding sites identified by ChIP-seq experiments
Ivan Yevshin et al.
NUCLEIC ACIDS RESEARCH (2017)
Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity
Myoung Sook Kim et al.
ONCOTARGET (2017)
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin
Yiwen Jiang et al.
CELL REPORTS (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor
Nathan C. Sheffield et al.
BIOINFORMATICS (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors
Pierre Bady et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
Guangchuang Yu et al.
BIOINFORMATICS (2015)
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
Yuan Xie et al.
EBIOMEDICINE (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff et al.
BIOINFORMATICS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The Tumor Microenvironment Strongly Impacts Master Transcriptional Regulators and Gene Expression Class of Glioblastoma
Lee A. D. Cooper et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction
Lea Cunningham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Temozolomide (Temodar)
J. R. Wesolowski et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Yukihiko Aikawa et al.
NATURE BIOTECHNOLOGY (2008)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression
M Jinnin et al.
MOLECULAR PHARMACOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
